Perflow Medical Expands Product Portfolio with First Clinica

Perflow Medical Expands Product Portfolio with First Clinical Use of the Stream™17 Dynamic Neuro-Thrombectomy Net


Share this article
Share this article
NETANYA, Israel, April 29, 2021 /PRNewswire/ -- Perflow Medical, a private, Israeli-based innovator for neurovascular treatments, today announced the first successful clinical use of the Stream™17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, to effectively treat hemorrhagic and ischemic stroke patients. Built on the proprietary CEREBRAL NET™ technology, the Stream17 device is the latest product portfolio addition that also includes the recently commercialized Cascade™17 Dynamic Non-Occlusive Remodeling Net for coil embolization of intracranial aneurysms. These low-profile product offerings further expand the range of brain vessels that can now be treated with Perflow's unique CEREBRAL NET technology. The first clinical procedures were successfully completed by Prof. Karlis Kupcs, head of Radiology at the Pauls Stradins Clinical University Hospital in Riga, Latvia.

Related Keywords

United States , United Kingdom , Israel , London , City Of , Paul Bhogal , Mark Vekemans , Barts Health , Cascade Net , Stream Net , Perflow Medical , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , இஸ்ரேல் , லண்டன் , நகரம் ஆஃப் , பால் போகல் , மரப்பட்டைகள் ஆரோக்கியம் , அடுக்கை நிகர , ஸ்ட்ரீம் நிகர ,

© 2025 Vimarsana